Medtronic Neurovascular Clinical Affairs
Clinical trials sponsored by Medtronic Neurovascular Clinical Affairs, explained in plain language.
-
New device aims to seal brain aneurysms without open surgery
Disease control Recruiting nowThis study tests a device called Artisse, which is placed inside a brain aneurysm to block blood flow and prevent rupture. It involves 300 people aged 18-75 with wide-neck aneurysms that are either unruptured or recently ruptured. The main goal is to see if the device safely and …
Phase: NA • Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New device for brain aneurysms under Real-World watch
Disease control Recruiting nowThis study follows 118 people getting a special device called Pipeline Vantage to treat brain aneurysms. The device is placed inside the blood vessel to block the aneurysm and prevent rupture. Researchers will check how well it works and if there are any problems one year after t…
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New registry to track stroke device performance in daily practice
Knowledge-focused Recruiting nowThis study is a registry that will follow 1500 adults treated for acute ischemic stroke with Medtronic devices. Researchers will track safety, how well the devices restore blood flow, and whether patients regain independence after 90 days. The goal is to see how these devices wor…
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive registry tracks Real-World performance of stroke and aneurysm devices
Knowledge-focused Recruiting nowThis registry is following 4,000 people who have been treated with Medtronic devices for brain aneurysms or ischemic stroke. Researchers are tracking how well the devices work in everyday medical practice, including how often aneurysms are fully closed and how many patients regai…
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC